New Zealand 3D Imaging Market Analysis Report 2022 to 2030

New Zealand 3D Imaging Market Analysis

$ 3999

New Zealand's 3D imaging market is projected to grow from $xx Bn in 2022 to $xx Bn by 2030, registering a CAGR xx% during the forecast period of 2022-30. The market will be driven by rising demand for advanced medical imaging technologies, as well as technological breakthroughs and increased awareness of the advantages of 3D imaging. The market is segmented by product, application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers, and Philips Healthcare

ID: IN10NZDH001 CATEGORY: Digital Health GEOGRAPHY: New Zealand AUTHOR: Vidhi Upadhyay

Buy Now

New Zealand 3D Imaging Market Executive Summary

The New Zealand 3D Imaging market is projected to grow from $xx Bn in 2022 to $xx Bn by 2030, registering a CAGR xx% during the forecast period of 2022 - 2030. Current healthcare spending per capita in New Zealand increased from $4,037.46 in 2018 to $4,211.05 in 2019. Because of the growing population, the need for healthcare services has increased in recent years. The bigger the healthcare expense, the greater the need for industrial output. Total health spending is predicted to rise in 2022-23. According to The Global Cancer Observatory 2020, out of a total population of 4.8 Mn, the number of new cases of cancer was 0.035 Mn with 0.01 Mn deaths. In New Zealand, 0.175Mn people are living with heart disease and a New Zealander dies from heart disease every 90 minutes.

In New Zealand, 3D medical imaging has become an indispensable tool in the healthcare business. These technology-enabled images give a more thorough and precise depiction of the human body, which can assist in the diagnosis and treatment of a variety of medical disorders. Diagnose and treatment planning, minimally invasive surgery, radiation therapy planning, cardiac imaging, and neurological imaging are the most prevalent applications of 3D medical imaging in New Zealand.

In November 2020, The MARS Programme, a collaboration between the universities of Canterbury and Otago and MARS Bioimaging Ltd, is developing a spectral molecular scanner that produces 3D color pictures of items within the body such as bone, soft tissue, and prosthetic joints. From December 1, 2021, Mercy Radiology and Mercy Breast Clinic are using 3D Mammography/Tomosynthesis as their new standard of care for breast screening and diagnosis for all patients.

Market Dynamics

Market Growth Drivers

Several variables drive the New Zealand 3D medical imaging industry. The country's aging population is driving up demand for medical imaging services, as the prevalence of chronic illnesses rises with age. The increasing frequency of chronic illnesses such as cancer, heart disease, and musculoskeletal issues is driving demand for improved medical imaging technologies such as 3D medical imaging. The growing popularity of minimally invasive surgical techniques is driving up demand for 3D medical imaging, as these treatments need comprehensive photographs of the human body to help in planning and execution.

Market Restraints

The high cost of 3D medical imaging equipment is a significant impediment to market expansion since these technologies can be prohibitively expensive for many healthcare institutions and patients. Concerns about radiation exposure with some forms of 3D medical imaging, such as CT scans, may limit demand for these services. Moreover, the shortage of skilled professionals, limited reimbursement for 3D imaging services, and other regular imaging services offered at lower costs pose competition to 3D imaging impeding the growth and adoption of the 3D imaging market.

Competitive Landscape

Key Players

GE Healthcare
Siemens Healthineers
Philips Healthcare
Fujifilm Medical Systems
Canon Medical Systems Corporation
Toshiba Medical Systems
Hitachi Medical Systems

Notable Deals

November 2022, At RSNA, Philips introduces new AI-enhanced informatics solutions having an integrated diagnostic strategy that combines radiology, cardiology, pathology, and oncology to securely unify data and pictures throughout the organization, allowing for an earlier and more conclusive diagnosis
November 2022, GE HealthCare announced partnerships with Accuray, Elekta, and RaySearch to combine GE HealthCare's imaging capabilities with precision radiation therapy to give cancer patients early diagnosis and improved treatment alternatives
In July 2022, GE Healthcare will release The Voluson Expert 22, a next-generation ultrasound device for pregnant women
June 2022, Siemens Healthineers Cios Spin with The Intuitive Ion System FDA certification allowed for seamless cone beam CT scans during robotic bronchoscopy treatments

Healthcare Policies and Regulatory Landscape

The Ministry of Health and The Medical Radiation Technologists Board have primary responsibility and policy for 3D medical imaging in New Zealand. The Ministry of Health is in charge of monitoring the development and application of medical imaging policy in the country, including 3D medical imaging. The New Zealand Radiology Board, on the other hand, is in charge of defining and maintaining national standards for radiology practice, including the use of 3D medical imaging technology.

Reimbursement Scenario

In New Zealand, reimbursement for 3D medical imaging is given by the government through the publicly financed health system known as the New Zealand Health System (NZHS). The bulk of healthcare services in New Zealand are covered by the NZHS, including medical imaging. The amount of compensation for 3D medical imaging services varies based on the type of service performed, the complexity of the case, and other considerations. In general, 3D medical imaging reimbursement in New Zealand is deemed sufficient, while there may be some variance in the degree of payment for different types of services and healthcare providers.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

New Zealand 3D Imaging Market Segmentation

By Product (Revenue, USD Billion):

The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.

X-ray Imaging Systems
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Nuclear Imaging systems

By Application (Revenue, USD Billion):

The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.

Cardiology
Neurology
Orthopedics
Gynecology
Oncology
Others (Urology, etc.)

By End User (Revenue, USD Billion):

Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.

Hospitals
Diagnostic Imaging Centers
Other End Users

By Portability (Revenue, USD Billion):

The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.

Stationary
Mobile

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.